OMER Omeros Corporation
9,198
$3.51
$0.05
(1.40%)
| Watchers | 9,198 |
| 52-Wk Low | $0.92 |
| 52-Wk High | $7.80 |
| Market Cap | $203.38M |
| Volume | 198,185.00 |
| 52-Wk High | $7.80 |
| 52-Wk Low | $0.92 |
Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024Business Wire • about 23 hours ago
Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter and year ended March 31, 2024, on Wednesday, May 15, 2024, after the market...
Share to Feed
Omeros Corporation (Nasdaq: OMER) today announced that interim analysis data from its ongoing Phase 2 study of OMS906 in patients with paroxysmal nocturnal hemoglobinuria submitted to the 2024...
Rocky Mountain Advisers LLC trimmed its holdings in shares of Omeros Co. (NASDAQ:OMER - Free Report) by 20.0% in the fourth quarter, according to its most recent filing with the Securities and...
StockNews.com upgraded shares of Omeros (NASDAQ:OMER - Free Report) from a sell rating to a hold rating in a report published on Wednesday.
Omeros Price Performance
Omeros stock opened at $3.15 on...
Related Stocks: NAS:OMER...
Investors considering a purchase of Omeros Corp (OMER) stock, but tentative about paying the going market price of 3.02/share, might benefit from considering selling puts among the alternative...
Reduced Net Loss and Strategic Developments Mark Omeros Corp's Year-End FinancialsRelated Stocks: OMER...
Omeros GAAP EPS of -$0.63 misses by $0.07...
Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...